If patients with high titers of anti-IFN-γ autoantibodies presented with recurrent and refractory infections, more aggressive treatments such as plasmapheresis to deplete monoclonal antibodies, B-cell depletion, and suppression of B-cell survival factors could be taken into consideration [32–34]. Here, IFNG is linked to infection.